328P Patient-reported outcomes of a switch to maintenance endocrine therapy following induction chemotherapy versus continuation of chemotherapy in ER-positive HER2-negative metastatic breast cancer: A randomized, open-label, phase II clinical trial
| Autor: | Saji, S., Taira, N., Morita, S., Kitada, M., Takano, T., Takada, M., Ohtake, T., Toyama, T., Kikawa, Y., Hasegawa, Y., Fujisawa, T., Kashiwaba, M., Ishida, T., Nakamura, R., Yamamoto, Y., Toh, U., Iwata, H., Masuda, N., Ohno, S., Toi, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S376-S376 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|